China Pharma (NYSE:CPHI) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Thursday. The firm issued a hold rating on the stock.

China Pharma Stock Performance

NYSE:CPHI opened at $0.21 on Thursday. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.79 and a quick ratio of 0.26. China Pharma has a fifty-two week low of $0.13 and a fifty-two week high of $0.60. The business has a 50 day moving average price of $0.20 and a 200-day moving average price of $0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.